Park's research is focused on drug delivery systems and biomaterials—his recent research centers around developing long-acting injectable (LAI) formulations that can deliver drugs for months. In particular, he focuses on understanding the biodegradable polymer properties for developing LAI systems for delivery of opioid antagonists for 2-6 months to treat opioid and alcohol use disorders.